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Available online 28 October 2011Colonymorphology variation of Burkholderia pseudomallei is a notable feature of a proportion of
primary clinical cultures from patients with melioidosis. Here, we examined the hypothesis
that colony morphology switching results in phenotypic changes associated with enhanced
survival under adverse conditions. We generated isogenic colony morphology types II and III
from B. pseudomallei strain 153 type I, and compared their protein expression profiles using
2D gel electrophoresis. Numerous proteins were differentially expressed, the most
prominent of which were flagellin, arginine deiminase (AD) and carbamate kinase (CK),
which were over-expressed in isogenic types II and III compared with parental type I. AD
and CK (encoded by arcA and arcC) are components of the arginine deiminase system (ADS)
which facilitates acid tolerance. Reverse transcriptase PCR of arcA and arcCmRNA expression
confirmed the proteomic results. Transcripts of parental type I strain 153 arcA and arcC were
increased in the presence of arginine, in a low oxygen concentration and in acid. Comparison
of wild type with arcA and arcC defective mutants demonstrated that the B. pseudomallei ADS
was associated with survival in acid, but did not appear to play a role in intracellular survival
or replication within the mouse macrophage cell line J774A.1. These data provide novel
insights into proteomic alterations that occur during the complex process of morphotype
switching, and lend support to the idea that this is associated with a fitness advantage in
vivo.
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Burkholderia pseudomallei is an environmental Gram-negative
bacillus and the cause of melioidosis, a life-threatening infec-
tion endemic to Southeast Asia and Northern Australia [1,2].
Melioidosis presents with a broad clinical spectrum ranging
from mild localized infection to rapidly fatal septicemia. The
more severe end of the spectrum is common, and infection
is associated with a mortality rate of around 40% in northeast
Thailand where the majority of cases are reported. Notable
features relating to treatment include a slow response to
antimicrobial drugs, the need for prolonged antimicrobial
therapy, and relapse despite apparently adequate antibiotic
treatment [1–3].
The colony morphology of B. pseudomallei on Ashdown agar
(a selective medium used by laboratories that isolate this
organism on a regular basis) is usually purple, wrinkled, and
likened to a cornflower head. This appearance has been
classified as type I, with the description of a further six less
common types (types II to VII) during a study of primary plates
from diagnostic cultures [4]. This observation can be explained
by the process of colony morphology switching, a reversible
event in which a given colony type can switch to an alternative
type. Previously, we demonstrated that reversible alterations in
B. pseudomallei morphotype were associated with reproducible
and reversible changes in bacterial length, production of extra-
cellular enzymes, biofilm formation, and flagella production
[4]. We have proposed that such changes reflect a mechanism
by which B. pseudomallei can survive unfavorable conditions.
Although most likely to have evolved in response to survival
in the environment, this may have important implications for
host–pathogen interactions and persistence in the human
host following infection.
Evidence for the role of B. pseudomallei colony morphology
switching in disease comes from both animal and in vitro
models. In an experimental mouse model, type II appeared
to become adapted for persistence, and type III was associated
with switching to type I or II [4]. Colonymorphology switching
has also been reported to occur after uptake of B. pseudomallei
by macrophages in vitro, with a difference in the rate of bacte-
rial replication between the different morphotypes after up-
take [4,5].
The objective of this study was to expand on the number of
proteins known to undergo differential expression during
colonymorphology switching, and to provide proof of concept
that one or more of these proteins are involved in survival
under adverse conditions. We generated isogenic types II
and III from parental type I using starvation conditions, and
compared protein expression by these three types using 2D
gel electrophoresis. Numerous proteins were observed to be
differentially expressed, the most prominent of which were
flagellin, arginine deiminase (AD) and carbamate kinase (CK),
which were over-expressed in isogenic types II and III com-
pared with parental type I. AD and CK (encoded by arcA and
arcC) are components of the arginine deiminase system
(ADS) that catalyzes the metabolism of arginine to ornithine,
ammonia, and CO2 with the generation of ATP [6]. We hypoth-
esized that the ADS facilitated adaptation and survival in
adverse environments. We examined this question usingtranscript analysis of arcA and arcC, and by comparing survival
of a parental strain versus mutants defective in each of these
two genes after exposure to acid and following uptake by
macrophages in vitro.2. Materials and methods
2.1. B. pseudomallei strains and isolation of isogenic
morphotypes
B. pseudomallei strain 153 type I was isolated from the blood of
a patient admitted to Sappasithiprasong hospital, Ubon
Ratchathani, Thailand in 2002. Two isogenic variants defined
on the basis of colony morphology appearance as types II
and III were obtained from the parental type I isolate using
nutritional limitation, as described previously [4]. In brief, a
single colony of type I was cultured in trypticase soy broth
(TSB) at 37 °C under static conditions in air for 21 days. Serial
dilutions were spread plated onto Ashdown agar, incubated
at 37 °C in air for 4 days and the colony morphologies classi-
fied using a morphotyping algorithm described previously
[4]. Isogenic types II and III were harvested and stored in TSB
containing 20% glycerol at −80 °C, (a condition under which
colony morphotype is stable) until use. The three isogenic
types had identical banding patterns by pulsed-field gel elec-
trophoresis (PFGE) using SpeI restriction enzyme digestion [4].
2.2. Protein extraction
Protein extraction was performed on two separate occasions
for the three isogenic morphotypes. A single colony of B.
pseudomallei picked from Ashdown agar was cultured in
100 ml of Luria-Bertani (LB) broth at 37 °C with shaking at
200 rpm for 18 h. Bacteria were centrifuged at 4500×g for
30 minat 4 °C,washedoncewith cold PBSand then resuspended
in 1ml of a cold lysis buffer containing 5 mM EDTA and 1mM
phenylmethylsulfonyl fluoride (PMSF) [7]. The suspension was
sonicated on ice at 22% amplitude at 1 second pulse intervals
for 3 min, and the lysate centrifuged at 14,000×g for 3 min at
4 °C. The supernatant was collected and sterilized by passage
through a 0.2 μm filter and stored at −80 °C until use.
2.3. Two-dimensional (2D) gel electrophoresis
Protein samples were cleaned using the 2D clean-up kit (GE
Healthcare Bio-Sciences), and the concentration determined
with the 2D quantification kit (GE Healthcare Bio-Sciences)
using BSA as a standard. Seven hundred micrograms of
protein was mixed with rehydration buffer (8 M Urea, 2%
CHAPS, 60 mMDTT, 0.5% IPG buffer pH 4–7 and 0.002% bromo-
phenol blue) to a total volume of 340 μl per immobiline dry
strip. A 18-cm IPG strip pH 4–7 was rehydrated with this sam-
ple solution for 12 h at room temperature. Isoelectric focusing
(IEF) was performed using an Ettan IPGphor 3 isoelectric
focusing system (GE Healthcare Bio-sciences) at 20 °C. The
running steps were set as follows: step 1: 500 V for 1 h, step
2: 1000 V for 1 h, step 3: 8000 V for 3 h and step 4: 8000 V for
1.30 h. On completion, the strip was equilibrated in 5 ml
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glycerol, 2% SDS and trace amount of bromophenol blue) con-
taining 50 mg dithiothreitol (DTT) and 125 mg iodoacetamide
(IAA) with continuous shaking for 15 min. The strip was then
submerged in 1× SDS electrophoresis running buffer (25 mM
Tris–HCl, pH 8.3, 192 mM glycine, 0.1% SDS) and subjected to
second dimensional separation using a 12.5% acrylamide gel.
Protein separation was performed in a SE600 Ruby vertical
electrophoresis unit (GE Healthcare Bio-Sciences) using a
current/gel of 10 mA for 15 min and 20 mA until the dye
front was 1 mm from the bottom of the gel. Protein spots
were visualized with colloidal Coomassie blue G-250 stain
(8% ammonium sulfate, 0.8% phosphoric acid, 0.08% Coomas-
sie blue G-250 and 20% methanol). Gel images were captured
using an Image Scanner II and LabScan software version 5.0
(GE Healthcare Bio-Sciences). The intensity of protein spots
was initially compared by eye between isogenic types I vs. II
and I vs. III, and those with visible differences analyzed fur-
ther using ImageMaster 2D Platinum version 5.0 (GE Health-
care Bio-Sciences). Two protein preparations were examined
for each type in independent experiments.
2.4. In-gel digestion and protein identification by matrix-
assisted laser desorption/ionization time of flight mass spec-
trometry (MALDI-TOF MS)
Proteins of interest were picked from the gel using the Ettan
Spot Handling Workstation (GE Healthcare Bio-Sciences). Gel
plugs were washed twice with 100 μl 50 mM ambic/50%metha-
nol, dehydrated in 100 μl 75% acetonitrile (ACN) for 10min and
then dried. Plugs were rehydrated in 20mM ambic and digested
with 10 μl of trypsin solution at 37 °C for 1 h. Peptides were
extracted twice with 60 μl of 50% ACN/0.1% trifluoroacetic acid
(TFA) for 20min and with 40 μl of 50% ACN/0.1% TFA for
20min, then the two extracts were pooled and dried. Peptides
were resuspended in 3 μl of 50% ACN/0.1% TFA, then mixed
with equal volumes of matrix solution (α-cyano-4-hydroxy-
cinnamic acid in 50%ACN, 0.1% TFA and 2% w/v ammonium
citrate) and applied onto a target plate (MTP 384 polished
steel TF). All samples were analyzed using an Autoflex
MALDI-TOF MS (Bruker Daltonik, Bremen, Germany) at the
BioService Unit (BSU), National Science and Technology
Development Agency, Pathumthani, Thailand. Protein mass
fingerprints were searched for protein identity and sequence
using theMASCOT search engine (http://www.matrixscience.
com). Protein identification was achieved by a protein blast
search using the NCBI protein database. (http://blast.ncbi.
nlm.nih.gov/Blast.cgi). The cellular localization of proteins
was predicted using PSORTb version 3.0.2 (www.psort.org/
psortb).
2.5. Reverse transcriptase PCR for arcA and arcC gene
expression
B. pseudomallei cells were harvested and RNA extracted using
Trizol reagent (Invitrogen). RNA concentration was measured
using the Nanodrop method (Thermo Scientific). Primers were
designed for arcA (BPSL1743) and arcC (BPSL1745) using Primer-
BLAST (http://www.ncbi.nlm.nih.gov/tools/primer-blast). Prim-
er sequences are shown in Table 1, and primer binding sites inarcA and arcC are indicated in Fig. 1. One-step reverse transcrip-
tase (RT-PCR) was performed using 1 μg RNA and a Superscript
III One-step RT-PCR system (Invitrogen) with forward primer
AF and reverse primer AR for arcA, or forward primer CF and re-
verse primer CR for arcC (Fig. 1 and Table 1). The RT-PCR condi-
tionswere as follows: cDNA synthesis at 45 °C for 30min; initial
denaturation at 95 °C for 2 min; 35 cycles of denaturation at
94 °C for 15 s, annealing at 58 °C (arcA) or 64 °C (arcC) for 15 s,
and extension at 72 °C for 15 s; and a final elongation step at
72 °C for 5 min. The positive control was RT-PCR for 16S rDNA
amplification using primers Univ_16S_F and Univ_16S_R
(Table 1). The negative controls were arcA and arcC reactions
without reverse transcriptase (RT) enzyme. The amplified prod-
uct was run on a 1.5% agarose gel, stained with ethidium bro-
mide and visualized under UV light using GeneSnap V 6.08
(SynGene, Cambridge, England).
RT-PCR was used to determine arcA and arcC expression in
late log phase by B. pseudomallei strain 153 isogenic types I, II
and III. One colony of B. pseudomallei on Ashdown agar was in-
oculated into 5 ml LB broth and incubated at 37 °C with shak-
ing at 200 rpm for 12 h. The culture was centrifuged at
12,000 rpm for 5 min, and RNA extracted from the pellet and
quantified as described above.
RT-PCR was also used to determine arcA and arcC expres-
sion by B. pseudomallei strain 153 type I under a range of condi-
tions in vitro. One colony of B. pseudomallei on Ashdown agar
was inoculated into each of the following: (i) 5 ml LB broth at
pH 7.4; (ii) LB broth at pH 4.0; or (iii) LB broth at pH 7.4 contain-
ing 50 mM L-arginine. Duplicate broths were prepared for 5 ml
LB broth at pH 7.4, with one tube incubated at 37 °C in air with
shaking at 200 rpm and the other incubated with a loosened
cap at 37 °C under oxygen limiting conditions using an airtight
plastic container (Oxoid) with an AnaeroPack-MicroAero sys-
tem (MGC, Japan). After 12 h incubation, B. pseudomallei cells
were harvested and RNA extracted and quantitated as before.
1 μg RNA was analyzed for each experiment, and all experi-
ments were performed on 2 separate occasions.
2.6. Construction of arcA and arcC mutants and
complemented strains
The fragment mutagenesis method described by Lopez et al.
[8] was employed to generate arcA or arcC defective mutants
in B. pseudomallei strain 153. B. pseudomallei K96243 arcA and
arcC sequences were obtained from GenBank (accession num-
ber NC_006350, [9]). PCR primers corresponding to 5′ (arcA-F1
and arcA-R1) and 3′ fragments (arcA-F2 and arcA-R2) of arcA
(BPSL1743) and 5′ (arcC-F1 and arcC-R1) and 3′ fragments
(arcC-F2 and arcC-R2) of arcC (BPSL1745) were designed using
Primer-BLAST (http://www.ncbi.nlm.nih.gov/tools/primer-blast).
The primer sequences and product sizes are shown in Table 1.
Forward primers amplifying the 3′ fragments of these genes
(arcA-F2 and arcC-F2) were designed to have an oligonucleotide
tail homologous to the 3′ ends of 5′ fragments. DNA was
extracted from B. pseudomallei parental type I strain 153 using a
High Pure PCR template preparation kit (Roche) after overnight
culture in LB broth at 37 °C with shaking at 200 rpm. The 5′ and
3′ fragments of each gene were joined by PCR using arcA-F1 and
arcA-R2 or arcC-F1 and arcC-R2 primers, which was facilitated by
a tail on the 3′ forward primer to give a new PCR product with a
Table 1 – Primer pairs used in this study.
Primers Sequence (5′–3′) Position a Product size (bp)
arcA
arcA-F1 CTCAAGTCGGTGTCCATTCC 17–36 280
arcA-R1 ACGTTATCCGGCGTGATCT 278–296
arcA-F2 AGATCACGCCGGATAACGTGGTACCGTGTTCAGCTTCTG 838–857 317
arcA-R2 GTGTACGTGTTGCGGTCGTA 1114–1133
arcA-F1 CTCAAGTCGGTGTCCATTCC 17–36 1117
arcA-R2 GTGTACGTGTTGCGGTCGTA 1114–1133
arcA-comp-F ACATGTCCCAAGCCATCCCTCA (−2)–20 1261
arcA-comp-R GCTCAGTAGTCGACGGGGTCGCG 1237–1259
AF CACAACCTGCTGACCGAGACCGTG 217–240 220
AR CGCGAAACAGCGTGAGCACCTT 415–437
arcC
arcC-F1 GTATCGTCATCGCATTGGG 5–23 277
arcC-R1 AGGTTGCCCATTTCCTGTTC 262–281
arcC-F2 GAACAGGAAATGGGGTACCTTGATCGACAAGGATCTGTGC 608–627 334
arcC-R2 GAATCCCGTCGACCTTCAC 901–916
arcC-F1 GTATCGTCATCGCATTGGG 5–23 915
arcC-R2 GAATCCCGTCGACCTTCAC 901–916
arcC-comp-F CCGCACCCCGGGCACCGTTGACACAA (−40)–(−15) 996
arcC-comp-R CGCGCGCCCGGGCGGCATCACCG 934–956
CF CGCGCAGACGGAAGGGATGAT 228–248 240
CR CGGCACGACGCGGCGGAACTTG 447–468
16S
Univ_16S_F TGGCTCAGAACGAACGCTGGCGGC 21-44 336
Univ_16S_R CCCACTGCTGCCTCCCGTAGGAGGAGT 327-356
pEXKm5
OriT_F TCCGCTGCATAACCCTGCTTC 598-578 236
OriT_R CAGCCTCGCAGAGCAGGATTC 368-383
a Positions corresponding to the nucleotide sequence of the indicated genes as annotated on B. pseudomallei K96243 chromosome 1 (NCBI
Reference Sequence NC 006350) or the pEXKm5 sequence (GenBank accession number GQ200735).
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arcC-R1 and arcC-F2. These mutant constructs were cloned
into pGEM®_T Easy and transformed into Escherichia coli
DH5α. White colonies were selected using β-galactosidase indi-
cator medium containing 50 μg/ml 5-bromo-4-chloro-3-indolyl-
β-D-galactopyranoside (X-Gal) (Promega) plates containing
100 μg/ml ampicillin. Colonies containing the desired plasmids
were analyzed by PCR using primers flanking themutant alleles
(arcA-F1 and arcA-R2 or arcC-F1 and arcC-R2). The products were
checked for correct size by agarose gel electrophoresis and veri-
fied by DNA sequencing.Fig. 1 – Gene organization of the arginine deiminase system (AD
arrows. Highlights indicate the extent of DNA deleted in the arcAThe unmarked knockout cassettes assembled by PCR and
containing deletions in the arcA and arcC genes were cloned
into the non-replicative plasmid, pEXKm5 [8]. The pEXKm5-
mutant allele constructs were transformed into E. coli DH5α.
Plasmids were extracted and checked by PCR with primers
arcA-F1 and arcA-R2 or arcC-F1 and arcC-R2 for the correct
product sizes of target gene constructs. The pEXKm5-mutant
plasmids were then transformed into E. coli RHO3 and
delivered to the host B. pseudomallei strain 153 by conjugation
as previously described [8], resulting in integration of
the allelic replacement construct into the B. pseudomalleiS) of B. pseudomallei. Primer binding sites are indicated by
and arcC mutants.
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and chromosomal sequences. The merodiploid clones visual-
ized as blue colonies on LB agar containing 1000 μg/ml kanamy-
cin and 50 μg/ml 5-bromo-4-chloro-3-indolyl-β-D-glucuronide
(X-Gluc)were selected for PCRwithprimers flanking themutant
alleles (arcA-F1 and arcA-R2 or arcC-F1 and arcC-R2) (Fig. 1 and
Table 1).
For merodiploid resolution, clones were streaked onto
yeast extract tryptone (YT) agar (Yeast extract and tryptone,
BD; agar, Oxoid) containing 15% sucrose and 50 μg/ml X-Gluc
and incubated at 25 °C for 72 h. White colonies growing on
X-Gluc-containing medium (YT-sucrose-X-Gluc plate) were
selected and purified by streaking on the same medium and
incubating as described above. Merodiploid resolution leads
to formation of either a wild type or a mutant strain, which
were distinguished by PCR using primer sets flanking the
mutant deletion alleles primers (arcA-F1 and arcA-R2 or arcC-
F1 and arcC-R2) and the oriT pEXKm5 plasmid backbone
sequences. In contrast to BP153, arcA and arcC mutants
yielded smaller DNA fragments for the deleted region and
did not yield oriT associated PCR products. Both mutants and
wild type strain did not grow on LB agar with 1000 μg/ml
kanamycin.
Complemented strains were constructed using the same
pEXKm5-based allele replacement approach. The forward
and reverse primers corresponding to the relevant regions
of the genome sequences were designed and their sequences
and locations are shown in Table 1 and Fig. 1, respectively
(arcA-comp-F and arcA-comp-R or arcC-comp-F and arcC-
comp-R primers). The PCR amplicons (arcA 1261 bp and arcC
996 bp) contained wild type B. pseudomallei strain 153 arcA
and arcC sequences plus upstream and downstream
sequences. The constructs were cloned into pEXKm5 [8],
transformed into E. coli RHO3 and delivered to B. pseudomallei
mutants by conjugation, resulting in merodiploid formation.
Sucrose selection was employed for merodiploid resolution
resulting in generation of wild type sequences containing
strains as well as strains thatmaintained the deletion alleles.
PCRs were performed with primers flanking deleted alleles to
screen for strains that had the mutant alleles replaced with
wild type sequences. PCR with oriT specific primers was
used to demonstrate the absence of pEXKm5 plasmid
backbone.
Gene deletions were verified by RT-PCR following gene
inductionusing L-arginine andoxygen limitation. B. pseudomallei
was cultured onLBagar containing 50mML-arginine at 37 °C for
24 h under oxygen limitation as described above. Bacteria were
harvested, and the RNA extracted, quantified and analyzed as
described above.
2.7. Growth curve analysis
Colonies of B. pseudomallei 153 wild type, arcA or arcC mutants
were picked from Ashdown agar, suspended in sterile PBS and
adjusted to an optical density (OD) at 600 nm to obtain bacte-
rial suspensions of approximately 1×106 cfu/ml. One hundred
microlitres of this suspension was added to 10 ml of LB and
incubated at 37 °C in air with shaking at 200 rpm for 24 h. At
1, 3, 6, 9, 12, 15 and 24 h a 500 μl aliquot of bacterial culture
was removed for turbidity measurements at 600 nm.2.8. Susceptibility of B. pseudomallei to acid
B. pseudomallei strain 153 type I (wild type), arcA, arcC mutants
and complemented strains with restored genotypes were har-
vested from Columbia agar plates following incubation over-
night 37 °C in air, then washed and resuspended in PBS. The
suspension was adjusted to an OD at 600 nm to obtain a bacte-
rial concentration of approximately 1×108 cfu/ml. The number
of bacteria in the inoculum was verified by plate count. One
hundred microlitres of suspension was inoculated into 5 ml of
LB broth pH 3.0 or 4.0 containing 50mMarginine, and incubated
at 37 °C with shaking at 200 rpm for 6 h. The numbers of viable
bacteriawere quantified by plating serial dilutions on Columbia
agar plates. Percent survival was calculated by (number of via-
ble bacteria×100)/number of bacteria in starting inoculum.
The experiment was performed in triplicate.
2.9. Growth of B. pseudomallei under oxygen limitation
B. pseudomallei wild type, arcA or arcC mutants grown over-
night on LB agar were suspended in PBS, the bacterial cell
counts adjusted to approximately 1×108 cfu/ml and then di-
luted using 10-fold serial dilutions in PBS. Ten microlitres of
bacterial suspension from each dilution was dropped in tripli-
cate onto two sets of LB agar plates adjusted to pH 7.4. One set
of plates were incubated at 37 °C in air, and the second set in-
cubated at 37 °C in an AnaeroPack-MicroAero system as de-
scribed above. The numbers of viable bacteria were
determined at 48 h and compared with the bacterial count in
the starting inoculum, and presented as bacterial survival
(cfu/ml). The experiment was performed in triplicate on two
separate occasions.
2.10. Interaction of B. pseudomallei with macrophages
Amousemacrophage cell line J774A.1 (ATCC TIB-67) was used
in this study. Cells were maintained in Dulbecco's modified
Eagle medium (DMEM, Invitrogen) supplemented with 10%
fetal bovine serum (PAA Laboratories, Austria). The invasion
assay was performed as previously described [4]. In brief, B.
pseudomallei cells from an overnight culture of wild type, arcA
or arcC mutants on Ashdown agar were suspended in PBS,
the bacterial cell density adjusted using OD at 600 nm and
then diluted in PBS. This was used to inoculate a 24-well
plate with each well containing an overnight culture of
1×105 J774A.1 cells to obtain a multiplicity of infection (MOI)
of approximately 10 bacteria per cell. The MOI was verified
by bacterial colony counting on Columbia agar. Infected
J774A.1 cells were incubated at 37 °C in 5% CO2 for 2 h, the me-
dium replaced with medium containing 250 μg/ml of kanamy-
cin and then incubated for a further 2 h to kill external
bacteria, before replacing with fresh medium containing
20 μg/ml of kanamycin. At the indicated time points, the
cells were washed three times, lysed, and the cell lysates seri-
ally diluted in PBS and spread plated on Ashdown agar to ob-
tain the bacterial count. The percentage of bacteria that were
cell-associated was calculated by (number of associated
bacteria×100)/number of bacteria in the inoculum. The ex-
periment was performed in triplicate on two separate
occasions.
Table 2 – Summary of altered-protein expression of stationary phase parental B. pseudomallei strain 153 type I and isogenic
colony variant types II and III.
Functional
category
Altered protein Spot
number
Gene
designation
Locus
ID
Mass PI Score Ratio type
II/I or III/I
Protein location/specific
function
II III
Upregulated proteins
Amino acid
transport and
metabolism
Arginine deiminase 66 arcA BPSL1743 46,422 5.57 359 1.58 2.42 Cytoplasmic
Arginine deiminase 67 arcA BPSL1743 46,422 5.57 241 10.38 21.0 Catalyzes the degradation
of arginine to citruline
and ammonia
Carbamate kinase 20 arcC BPSL1745 33,507 5.54 129 1.99 3.01 Cytoplasmic
Carbamate kinase 45 arcC BPSL1745 33,507 5.54 130 6.67 10.13 Reversible synthesis of
carbamate and ATP from
carbamoyl phosphate and
ADP
Hypothetical 32 – BPSL1591 40,435 5.78 208 3.55 2.82 Cytoplasmic
Similar to Agrobacterium
tumefaciens dehydrogenase
Energy production
and conversion
Ferredoxin-NADP
(H) reductase
75 fpr BPSL0241 28,983 5.78 155 2.82 2.49 Cytoplasmic
FAD-containing enzyme
that catalyzes the reversible
electron transfer between
NADP(H) and electron
carrier proteins such as
ferredoxin and flavodoxin
Carbohydrate
metabolism
UDP-glucose
dehydrogenase
73 udg BPSL2511 50,802 5.34 93 1.53 3.47 May have multiple
localization sites
Cell wall/membrane
biogenesis
Chaperone Chaperonin GroEL 29 groEL BPSL2697 57,137 5.13 159 0.51 3.00 Cytoplasmic
60 kDa chaperone family;
promotes refolding of
misfolded polypeptides
especially under stressful
conditions
Cell motility Flagellin 6 fliC BPSL3319 39,233 5.05 106 10.72 15.63 Extracellular
Structural flagella protein
Down-regulated proteins
Lipid transport
and metabolism
Succinyl-CoA:3-
ketoacid-coenzyme
A transferase
subunit A
53 scoA BPSL1955 25,373 5.6 155 0.103 0.105 Cytoplasmic
Coenzyme A (CoA)
transferases catalyze the
reversible transfer of CoA
from one carboxylic acid to
another
Succinyl-CoA:3-
ketoacid-coenzyme
A transferase
subunit B
54 scoB BPSL1954 22,330 4.7 131 0.133 0.322 Cytoplasmic
Coenzyme A (CoA)
transferases catalyze the
reversible transfer of CoA
from one carboxylic acid to
another
Energy production
and conversion
Inorganic
pyrophosphatase
22 ppa BPSL1021 19,206 5.37 88 0 0 Cytoplasmic
Catalyzes the hydrolysis of
pyrophosphate to phosphate
Betaine aldehyde
dehydrogenase
61 aldA BPSL1550 50,738 5.67 250 0.490 0.412 Cytoplasmic
Catalyses the conversion of
betaine aldehyde to glycine
betaine
Amino acid
transport and
metabolism/
2,3,4,5-
tetrahydropyridine-
2,6-dicarboxylate
N-
succinyltransferase
74 – BPSL2169 29,660 5.68 181 0.136 0.386 Cytoplasmic
Catalyzes the formation of
N-succinyl-2-amino-6-keto-
pimelate from succinyl-CoA
and tetrahydrodipicolinate
in the lysine biosynthetic
pathway
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Table 2 (continued)
Functional
category
Altered protein Spot
number
Gene
designation
Locus
ID
Mass PI Score Ratio type
II/I or III/I
Protein location/specific
function
II III
Inorganic ion
transport and
metabolism
Sulfurtransferase 49 sseA BPSS1766 31,119 5.98 127 0.345 0.170 Cytoplasmic Cyanide
detoxification
Catalyzes thiosulfate and
cyanide to sulfite and
thiocyanate
Secondary
metabolites
biosynthesis,
transport and
catabolism
Non-ribosomally
encoded peptide/
polyketide
synthase
35 phyH BPSS1183 35,611 5.77 102 0.725 0.142 Cytoplasmic membrane
Pseudomonas syringae
syringomycin biosynthesis
enzyme or B. thailandensis
bactobolin
Posttranslational
modification,
protein turnover
Oxido-reductase 62 – BPSL2748 23,904 5.75 95 0.085 0.081 Cytoplasmic
Peroxidase
Antioxidant proteins
Multifunctional Acetoacetyl-CoA
reductase
72 phbB BPSS1916 26,583 6.3 190 0.763 0.105 Cytoplasmic
Synthesizes
polyhydroxybutyrate (PHB)
from acetyl coenzyme A
(acetyl-CoA) in Ralstonia
eutropha.
Unknown Hypothetical
protein
71 – BPSL1549 23,384 5.14 66 0.417 0.091 Unknown
Protein spots were separated using a pH range 4–7 and examined using 2D Image master software. Only those proteins with a reproducible
change in spot intensity volume between types I versus II or I versus III colony variants of ≥1.5-fold in two independent experiments are
reported. Functional groups were identified based on COG functional category (http://www.ncbi.nlm.nih.gov). PSORTb was used to predict
protein localization (http://www.psort.org/psortb).
Down-regulated proteins
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Statistical analysis was performed using the statistical pro-
gram STATA version 11 (Stata Corp, College Station, TX,
USA). Log transformation of continuous dependent variables
was performed. Repeated measures ANOVA was used to
compare continuous dependent variables between wild
type, arcA and arcC mutants. P value for pairwise compari-
sons was adjusted using the Benjamini–Hochberg method
[10]. Differences between wild type and the two mutants
were considered to be statistically significant when the P
value was ≤0.05.3. Results
3.1. Proteomic analysis of B. pseudomallei strain 153
types I, II and III
Proteomic analysis of B. pseudomallei strain 153 revealed over
700 protein spots. Protein expression was compared between
B. pseudomallei strain 153 types I versus II, and types I versus
III using 2D Image master software. Only those proteins with
a reproducible difference of at least 1.5 fold in spot intensity
volume in two independent experiments are reported. Differ-
ential expression was observed for 19 protein spots (Table 2).
Of these, 9 proteins showed increased expression in types II
and III compared with type I, and 10 proteins had reduced
expression in types II and III compared with type I (Table 2).No proteins were differentially expressed in only type II or
type III.
These 19 proteins were identified and grouped by COG
functional category (http://www.ncbi.nlm.nih.gov).
Five of the 9 proteins with increased expression in types II
and III were involved in amino acid transport and metabo-
lism. Two protein spots (number 66 and 67, Fig. 2) were iden-
tified as arginine deiminase (AD), and a further two spots
(number 20 and 45, Fig. 2) were identified as carbamate kinase
(CK). These two proteins are part of the arginine deiminase
system. The fifth was a hypothetical protein (spot 32) with
similarity to a dehydrogenase of Agrobacterium tumefaciens.
Other proteins with increased expression in types II and III
were ferredoxin-NADP reductase (spot 75), UDP-glucose dehy-
drogenase (spot 73) and chaperone GroEL protein (spot 29)
(Table 2). Flagellin (spot 6) was markedly over-expressed in
types II and III (11 and 16 fold, respectively) (Table 2 and Fig. 2).
Of the 10 down-regulated proteins in types II and III, two had
homology to succinyl-CoA (3-ketoacid-coenzyme A transferase
subunit A (spot 53) and subunit B (spot 54), and two proteins
were involved in energy production and conversion including
inorganic pyrophosphatase (spot 22). Another 3 proteins were
classified under transport andmetabolismof amino acids, inor-
ganic ions or secondary metabolites (Table 2). One protein was
classified as peroxidase (spot 62), one was classified as a multi-
functional protein identified as acetoacetyl-CoA reductase (spot
72), and the final protein was of unknown function coded by
BPSL1549 (spot 71) (Table 2 and Fig. 2).
Prediction of sub-cellular organization of proteins using
PSORTb demonstrated that almost all of these differentially
Fig. 2 – Proteomic profiles of B. pseudomallei strain 153 type I (A, D) and isogenic type II (B, E) and type III (C, F). Red circles are
used to highlight up-regulated proteins (A, B and C) or down-regulated proteins (D, E and F) in types II and III compared with
type I. Protein spot numbers relate to information provided in the text and Table 2.
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ment of bacterial cells, with the exceptions of flagellin protein
which is assembled in the cytoplasm and secreted across the
cell wall to be anchored to the cell membrane, and UDP-
glucose dehydrogenase which may be located in multiple
sites. BPSL1549 is a hypothetical protein of unknown location.
In Pseudomonas aeruginosa, AD and CK are encoded by arcA
and arcC[11]. Comparison of the genome of B. pseudomallei
strain K96243 and P. aeruginosa strain ATCC 15692 using
webACT (http://www.webact.org) demonstrated that the
gene organization of these two species are similar, with arcD,
arcA, arcB and arcC present in this gene order within an operon
structure (Fig. 1). The amino acid identity between B.
pseudomallei and P. aeruginosa was 79.4% for ArcA and 82.6%
for ArcC. We noted that that there was no similarity between
these two species in the region upstream of arcD, which in B.
pseudomallei contained BPSL1741 encoding a hypothetical pro-
tein and in P. aeruginosa contains an ANR box transcription
initiation site [11].3.2. arcA and arcC expression by RT-PCRRT-PCR was used to determine transcript levels of arcA and
arcC for isogenic B. pseudomallei strain 153 types I, II and III(Fig. 3A). This demonstrated higher transcript levels of arcA
and arcC for types II and III compared with type I, a finding
that is consistent with the proteomic data for these two
genes.
We proposed based on homology with these genes in P.
aeruginosa that B. pseudomallei arcA and arcC represented
genes of an arginine deiminase system. In other bacteria, the
ADS is activated by the presence of arginine [12–15] or growth
in reduced oxygen concentration [12–15]. We sought evidence
that this was also the case for B. pseudomallei by determined
transcript levels of B. pseudomallei strain 153 type I (parental
strain) arcA and arcC in LB broth at pH 7.4 with or without
arginine, after incubation in air or under oxygen limitation.
We observed that transcript levels were higher for both
genes following growth under oxygen limitation compared
with growth in air, and that arginine was a strong inducer of
gene expression (Fig. 3B). This provided additional evidence
that these genes are part of the ADS.
In other bacteria, the ADS is activated by, and provides pro-
tection against acid stress [12–15]. We compared transcript
levels after growth in LB broth at pH 4.0 versus pH 7.4 follow-
ing incubation in air or under oxygen limitation. A marked
increase was observed in transcript levels of arcA and arcC at
pH 4 compared with pH 7 after incubation in air, findings
that are consistent with the published literature.
Fig. 3 – Reverse transcriptase PCR analysis of arcA and arcC (A) Transcript of arcA, arcC and 16S RNA (control) for B. pseudomallei
strain 153 isogenic types I, II and III cultured in LB at 37 °C in air. M: 100–3000 bp ladder. (B) Transcript levels of arcA, arcC and
16S RNA for B. pseudomallei strain 153 type I (parental) cultured as follows: lane 1, LB broth pH 7.4; lane 2, LB broth pH 4.0; lane 3,
LB broth containing 50 mM L-arginine, pH 7.4 incubated at 37 °C in air; lane 4, LB broth at pH 7.4 incubated at 37 °C under
oxygen limiting conditions. M: 100–3000 bp ladder. (C) PCR analysis of B. pseudomallei strain 153 type I (parental), its arcA and
arcC mutants and complemented strains cultured in LB at 37 °C in air. The sizes of DNA fragments amplified with primer sets
arcA-F1 and arcA-R2 for arcA and arcC-F1 and arcC-R2 for arcC are indicated on the right of the respective panel. The larger
fragments are products obtained with B. pseudomallei strain 153 templates and the smaller fragments are products obtained
with arcA and arcC mutant templates. Lane 1, wild type; lane 2, arcA mutant; lane 3, arcC mutant; lane 4, arcA complemented
strain; lane 5, arcC complemented strain; and lane 6, negative control. M: 100–3000 bp marker ladder. (D) RT-PCR analysis of
arcA, arcC and 16 S rRNA transcript levels in B. pseudomallei strain 153 type I (parental), arcA and arcC defective mutants and
complemented mutants with a restored genotype. B. pseudomallei grown in LB agar containing 50 mM arginine at 37 °C for 24 h
under low oxygen conditions (inducers of arcA and arcC expression). Lane 1, wild type; lane 2, arcAmutant; lane 3, arcCmutant;
lane 4, arcA complemented strain; and lane 5, arcC complemented strain. M: 100–3000 bp marker ladder.
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mented strains
B. pseudomallei mutants defective in arcA or arcC were con-
structed by deletion mutagenesis using a pEXKm5-based
allele replacement strategy [8]. Mutants were verified by PCR
analysis. The presence of a 578 bp DNA fragment (Fig. 3C,
lane 2) and the absence of a 236 bp oriT fragment indicated
the desired mutant allele, while the wild type BP153 yielded
an arcA product of 1117 bp (Fig. 3C, lane 1). A similar analysis
indicated the presence of a 591 bp DNA fragment in the arcC
mutant (Fig. 3C, lane 3) and the absence of the 236 bp oriT
fragment, while the wild type yielded a 915 bp arcC product
(Fig. 3C, lane 1). These mutants were clearly distinguished
from unresolved merodiploids in that the merodiploids
yielded DNA fragments indicative of both mutant alleles and
integrated pEXKm5 vector sequence typified by oriT se-
quences (data not shown).
Complemented strains were constructed using the same
approach. The PCR product size using primers flanking delet-
ed alleles demonstrated that the complemented arcA and arcC
mutant strains had the 578 and 591 bp PCR fragments indicat-
ing deletion alleles replaced by wild type sequences which
yielded 1117 and 915 bp PCR products, respectively, whichwere the same as those observed with the parental strain
(Fig. 3C, lanes 4 and 5).
RT-PCR analysis was used to verify the deletion of arcA and
arcC genes in the mutants (Fig. 3D). This demonstrated that
arcA expression was only abolished in the arcA mutant (first
panel, lane 2), and arcC expression only in the arcC mutant
(second panel, lane 3). The 16S rRNA positive control samples
all yielded a 336 bp product (third panel). No amplification
was detected in the negative controls (data not shown).
The mutants and complemented strains had the same
colony morphotype as the parental strain. Growth curve anal-
ysis using starting inoculums of 1×106 cfu/ml in 10 ml LB
broth at 37 °C incubation with shaking demonstrated that
the doubling time of arcA and arcC mutants was not different
from that of wild type (P>0.1). The average doubling times of
wild type, arcA and arcC mutants were 37.2, 37.0 and
38.9 min, respectively. In all strains, log phase started at 6 h
and stationary phase at 15 h.
3.4. Effect of arcA and arcC mutations on B. pseudomallei
survival
Susceptibility to killing by acid was compared between B.
pseudomallei strain 153 type I (parental) and mutants defective
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arginine at pH 3.0 at 37 °C with shaking at 200 rpm for 6 h.
Growth of wild type at pH 3.0 led to a 1.5 log reduction from
the starting inoculum (1.0×106 cfu/ml). This compared with
the much more dramatic reduction from a starting inoculum
of 1.1×106 cfu/ml to no viable bacteria for both the arcA and
arcC mutants (P<0.001) (Fig. 4A). The complemented mutants
had a restored phenotype at pH 3.0, with a percentage survival
that was comparable to wild type (Fig. 4A).
Having shown that arcA and arcC transcripts were in-
creased in wild type in response to a low oxygen concentra-
tion, we investigated the effect on survival of arcA and arcC
under this condition. Serial dilutions of 1×108 cfu/ml of wild
type, arcA and arcC mutants were inoculated onto LB agar
adjusted to pH 7.4 and incubated at 37 °C in an AnaeroPack-
MicroAero system. Viable bacteria were enumerated and
compared to those on plates incubated in air. There was no
significant difference observed for survival in low oxygen
concentration between wild type, arcA or arcC mutants at pH
7.4 (P>0.1).Fig. 4 – Survival of wild type, arcA and arcC mutants and
complemented strains in acid (A) and in a J774A.1 mouse
macrophage cell line (B). (A) B. pseudomallei was exposed to
LB at pH 3.0 containing 50 mM arginine for 6 h at 37 °C.
Bacterial counts were determined by plating serial dilutions
onto Columbia agar plates. The results were obtained from
triplicate experiments. Data plots are mean±standard
deviations (SD). (B) J774A.1 macrophages were infected with
bacteria at a MOI of 10:1. The results represent mean
numbers of intracellular bacteria and standard deviations
(SD) at 4, 6 and 8 h after infection. Data are from two separate
experiments.3.5. Survival of arcA or arcC mutants in macrophages
We predicted that a defect in the ADS would not affect the ini-
tial bacterial-macrophage cell interaction, but that mutants
defective in arcA or arcC would have a survival disadvantage
following uptake. We defined the initial interaction based on
the number of cell-associated B. pseudomallei after 2 h incuba-
tion at a MOI of 10:1. No difference was observed betweenwild
type, arcA or arcC mutants, with 2.1%, 1.6% and 2.3%, respec-
tively, of the starting inocula becoming cell-associated. Extra-
cellular bacteria were removed at this stage, and the number
of intracellular bacteria determined after a total of 4, 6 or 8 h
of incubation. The number of bacteria counted at these time
points was comparable for wild type and both mutants
(Fig. 4B) (P>0.05 for all time points). These data suggest that
arcA and arcC are not required for intracellular survival in a
J774A.1 cell line.4. Discussion
The ADS is widely distribute among prokaryotes [6], and has
been linked to the ability of bacteria to withstand low pH
through the generation of alkali (ammonia). An ADS has
been shown to promote survival of Streptococcus suis, Listeria
monocytogenes, Streptococcus pyogenes and oral streptococci
under acid conditions in vitro [14–17], and to be a virulence
factor in an experimental mouse model of L. monocytogenes
infection [17]. The ADS system of S. pyogenes and S. suis has
also been reported to be involved in adhesion to and invasion
of epithelial cells [14,18].
The contribution of the ADS to bacterial fitness and disease
pathogenesis in the human host is largely speculative, but
includes some potentially important possibilities. For exam-
ple, it has been proposed that an ADS in L. monocytogenes is
involved in tolerance to acid during growth in low-pH foods,
during successful passage through the stomach, and survival
within the macrophage phagosome [17]. An ADS has also
been identified in Salmonella enterica serovar typhimurium that
was upregulated in response to low oxygen availability
and high osmolarity, conditions that are prevalent in the gut
[19]. A striking feature of the highly successful community-
associated methicillin-resistant Staphylococcus aureus (MRSA)
USA300 genome was the horizontal acquisition of a novel mo-
bile genetic element encoding an arginine deiminase pathway
(together with an oligopeptide permease system) [20]. The re-
lationship of these genes to the biological fitness of USA300 is
unknown, but it has been proposed that they may contribute
to bacterial growth and survival. The clearest relationship
between a bacterial ADS and humans is in relation to dental
caries, the generation of alkali by oral bacteria such as Strepto-
coccus gordonii and members of the mutans streptococci being
thought to play a key role in plaque pH homeostasis and re-
duction in risk of caries [21–23].
An ADS has not been described previously for B. pseudomallei,
but has been studied in P. aeruginosa [12,24,25]. In the absence of
oxygen andnitrate, P. aeruginosametabolizes arginine via the ar-
ginine deiminase pathway, which allows slow growth on rich
media [12]. The ADS facilitates survival of P. aeruginosa in a pH
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of ammonia with a resulting increase in pH [24]. A fascinating
observation was made for P. aeruginosa isolates recovered over
a period of 3 to 5 years from3 selected patients with cystic fibro-
sis, inwhich strainswith amutator or a non-mutator phenotype
demonstrated increased expression of the ADS, suggesting a
role for long-term adaptation in the human host [26].
The ADS has been reported to be induced by a variety of
stimuli in vitro, including the presence of arginine, reduced ox-
ygen tension, acid, temperature shifts and iron limitation
[12,13,18,25,27–29]. This is consistent with the findings
described here for B. pseudomallei. One or more of these stimuli
would be predicted to occur during bacterial infection in the
human host, including melioidosis where abscess formation is
common [1,2]. B. pseudomallei is a facultative intracellular bacte-
rium [5,30–33], and has been found in macrophages and multi-
nucleated giant cells in post-mortem tissue [34]. We predicted
that the ADS would be involved in survival after uptake by
macrophages in vitro, but this did not prove to be the case
for the mouse macrophage cell line J774A.1. Furthermore,
natural deletion of the ADS operon has been described in a clin-
ical B. pseudomallei isolate (strain 708a) thatwas shown to be vir-
ulent in a murine melioidosis model [35], indicating that this
system is not essential for bacterial survival or virulence in
vivo, but may nonetheless be important in persistence.
Proteins of the ADS were just two of numerous proteins
that were differentially expressed in B. pseudomallei types II
and III compared with type I. This suggests the involvement
of a global regulator, leading us to consider the regulation of
the ADS operon in other bacteria. Regulation appears to be
variable between different bacterial species, and is potentially
complex. For example, ArcR is a transcriptional regulator of
the ADS in S. gordonii [21], S. suis [16], and L. monocytogenes
[17]. Expression of an ADS in L. monocytogenes is alsomodulated
by both the alternative stress sigma factor σB and the central
virulence regulator PrfA [17], and multiple two-component
systems have been reported to modulate alkali generation in
S. gordonii in response to environmental stresses [36]. This
does not provide us with any indication as to the mechanism
for colony morphology switching.
Flagellin encoded by BPSL3319 (fliC) was highly expressed
in types II and III compared with type I. This finding supports
phenotypic evidence of flagella expression reported by us pre-
viously, in which electron microscopy revealed that the pro-
portion of flagellate bacteria of isogenic types I, II and III
were 10%, 56% and 85%, respectively [4]. Greater motility of
live bacteria was also observed by real-time microscopy
(RTM-3) for types II or III compared with type I, the proportion
of actively motile bacteria being 9%, 77% or 76% of the popula-
tion observed for isogenic types I, II and III, respectively [4].
The biological effect of increased flagellin expression in the
human host is not understood, and has numerous possible
explanations including the ability of bacteria to migrate to-
wards nutrients or away from adverse environments, and
involvement in interactions with host cells and the host im-
mune response.
Two proteins that were observed to be more highly
expressed by type I in comparison to type II or III were possi-
ble virulence determinants. The first of these was a protein
encoded by BPSS1183 with a putative function similar to aPseudomonas syringae syringomycin biosynthesis enzyme for
a phytotoxin or syringomycin product, a known virulence
factor that causes the phosphorylation of several membrane
polypeptides [37]. This has homology to a newly-described
bactobolin antibiotic in Burkholderia thailandensis E264 [38].
Also highly expressed in type I compared to type II or III was
an oxido-reductase, which has anti-oxidant activity. The ex-
pression of these proteins in type I is consistent with our pre-
vious finding that type I had greater resistance to killing by
hydrogen peroxide in vitro. The complex pattern of protein
expression changes observed for isogenic types II and III com-
pared with type I in B. pseudomallei strain 153 suggests the
simultaneous involvement of numerous bacterial factors in
the adaptive process associated with colony morphology
switching. Elucidation of just one of these factors provides
proof of concept that this was involved in bacterial survival
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